PF-04885614 is a highly potent NaV1.8 inhibitor, extracted from patent US2018328915. PF-04885614 has highly potential for neurological and neurodevelopmental diseases treatment. References: [1]. Brady MAHER, et al. Treatment of Neurological and Neurodevelopmental Diseases and Disorders Associated with Aberrant Ion Channel Expression and Activity. US20180328915A1.

纯度：≥98%

CAS：1480833-70-2